Company
RNAble
- Business model
- B2B
Record updated 28 September 2026
About
RNAble is a preclinical-stage biotechnology company developing a first-in-class small-molecule FTO inhibitor targeting cancers characterized by chromosomal instability (CIN)
Company
Record updated 28 September 2026
RNAble is a preclinical-stage biotechnology company developing a first-in-class small-molecule FTO inhibitor targeting cancers characterized by chromosomal instability (CIN)
A first look at RNAble’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.